Latest News
Electronic Health Record Use Varies Across Primary Care Specialties
FDA Adds Guillain-Barré Warning to Janssen/J&J COVID-19 Vaccine
WHO: Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots
Pfizer Presses US Scientists, Officials on Third Booster Shot
Inconsistent Evidence to Support the Efficacy, Safety of Muscle Relaxants for Treatment of Low Back Pain
Health Impairment in Spondyloarthritis Associated With High Disease Activity, Worsening Functionality, and Concomitant Fibromyalgia
Many States Move to Ban Vaccine Mandates, Passports in Public Schools
Model Estimates Routine Child Vaccine Doses Missed During 2020
COVID-19 Outcomes May Be Worse for People With Learning Disability
Robust Prescription Monitoring Programs Influence Discontinuation of Long-Term Opioid Use Patterns
FDA Approves Spinal Cord Stimulation Therapy for Painful Diabetic Neuropathy
Gender- and Ethnic-Specific Trends in Suicidality Among Adolescents in the US Between 1991-2019
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Pfizer to Meet With US Officials About COVID-19 Booster Shot
Latest Features
Management of COVID-19 in Transplant Recipients Evolved During Pandemic
Therapies used to treat COVID-19 in solid organ transplant recipients shifted since the pandemic began
Alcohol Withdrawal: Individualized Care and Pharmacologic Treatment
More than 50% of patients with alcohol use disorder develop alcohol withdrawal symptoms within hours of discontinuing or decreasing alcohol use.
Exploring Aspirin for the Treatment and Prevention of Migraines
Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
What Does the Future of the Mental Health Pandemic Hold?
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
Highlights of Virtual Congressional Briefing: Understanding the Immune Response to COVID-19
Panelists at a virtual congressional briefing, including James Kublin, MD, addressed critical questions about new diagnostic technologies, vaccine and treatment development, and the long-term impact of COVID-19 on patients who have recovered from the disease.
- Loading...
Loading...
Loading... 
Loading...